Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
OVER THE LAST year there has been a huge surge in seizures of a medication, typically used as a de-wormer in animals, but touted as a cure or preventative treatment against Covid-19.
Some 4,958 units of the medication were seized between July 2020 and July 2021, the Health Products Regulatory Authority (HPRA) confirmed to The Journal last week.
It represents an increase of over 3,000 per cent on the previous 12 months when just 158 units were seized.
Health authorities across the world have warned of potentially serious side effects associated with improper use of the medication, but misinformation groups continue to promote.
Buying online
Although the most typical use for ivemectin is in de-worming products for animals such as horses, there are approved versions of the medication for use in humans.
It can be prescribed for conditions in humans caused by parasitic worms as well as some skin conditions such as rosacea. Ivermectin products have not been approved for use as a Covid-19 treatment, or as a preventative measure.
A number of websites, many based in India, are selling the drug in pill form without the need for a prescription. There are also several social media chat forums instructing people on how to buy the drug without a prescription or linking them up with specific individuals who will sell it to them.
The use of this medication as a Covid treatment, or as a preventative drug to be taken daily, has been promoted by individuals and organisations that regularly share misinformation about the coronavirus, Covid vaccines and the pandemic in general. These types of posts are widely shared in Ireland.
These groups and individuals often cite studies that ‘prove’ its efficacy, but these studies have largely been deemed unreliable and in some cases at risk of bias.
The HPRA said ivermectin as a prescription-only medicine for human use must be subject of a ‘marketing authorisation’ granted the HPRA. All veterinary medicinal products supplied in Ireland, including ivermectin, must also be licensed either by the HPRA or by the European Medicines Agency.
The HPRA said the ivermectin units detained in the last year at port of entry have not been subject to these licensing or marketing authorisations and, therefore, are not authorised for sale in Ireland.
“Ivermectin is not currently authorised as a treatment for Covid-19 in Ireland and the HPRA continually recommends that patients do not seek to purchase prescription medicines that have not been prescribed by a medical doctor and dispensed by a registered pharmacy as there can be no guarantee as to their safety, quality or efficacy, in addition to the health risks for persons seeking to self-medicate,” the HPRA said.
There are a number of ivermectin veterinary medicinal products available to purchase from legitimate retailers in Ireland. These products can be purchased without the need for a prescription from a vet.
Although these retailers must be licensed and the products contain warnings stating the are for animal use only, there is no requirement for a retailer to request information from a customer about the reason they are purchasing the product.
The regulations around these types of veterinary medicinal products will change at the end of January next year when the government will remove an exemption to a European directive. From 28 January 2022, a prescription from a vet will be required to purchase any antiparasitics.
Advertisement
The evidence
A number of health experts have publicly promoted the use of ivermectin as a Covid-19 treatment. One of the most prominent groups is the US-based Front Line Covid-19 Critical Care Alliance (FLCCC).
Co-founder Dr Pierre Kory, who is an intensive care specialist, spoke to Newstalk’s Pat Kenny recently, telling him the drug has been “proven” to be effective against Covid-19.
He cited a number of studies and trials, but several have been dismissed due to factors such as insufficient evidence, risk of bias or a weak methodology. His claims have been factchecked by The Journal.
While many of the studies cited by those promoting the use of the drug as a Covid treatment have been deemed unreliable, there are two major ongoing trials which should help to provide further clarity.
In June this year, the University of Oxford said it was beginning an investigation into the use of ivermectin as a possible treatment for Covid. The study had so far recruited more than 5,000 volunteers from across the UK.
Following news of the ivermectin seizures in Ireland, the HSE has warned against the use of drug, stating that it is not an approved treatment for Covid-19 in Ireland or anywhere.
It said that while small studies have been done, “none suggested that this agent will have any benefit”.
Side effects
Experts have warned of potentially serious side effects of using this medication, particularly if the product was intended for use in animals as the dose can be significantly higher than is safe for humans.
Serious side effects of overdose include inflammation of the brain, coma, as well as liver toxicity.
There have been a small number of individual reports of patients hospitalised after overdosing on ivermectin, including a patient in Sydney, Australia earlier this month who had taken several drugs they ordered online.
The patient, who was Covid-positive, suffered vomiting and diarrhoea after overdosing on the medications.
Poison control centres in the US have also seen a surge in calls from people who are self-medicating with ivermectin, according to reports. There was a 245% increase in reported exposure cases from July to August from 133 to 459.
Ireland’s National Poisons Information Centre (NPIC), which is based at Beaumont Hospital in Dublin, told The Journal that it has been made aware of one instance of poisoning involving ivemectin this year.
The NPIC said it received two enquiries about the use of ivermectin for Covid-19 treatment this year and both enquiries related to this patient.
Readers like you are keeping these stories free for everyone...
Our Explainer articles bring context and explanations in plain language to help make sense of complex issues.
We're asking readers like you to support us so we can continue to provide helpful context to everyone, regardless of their ability to pay.
TheJournal.ie's Coronavirus Newsletter
TheJournal.ie's coronavirus newsletter cuts through the misinformation and noise with the clear facts you need to make informed choices. Sign up here
'The place is not functioning properly': Committees not back to work 3 months after election
Jane Matthews
2 hrs ago
1.3k
17
Press Freedom
White House to 'decide’ which news outlets cover Trump, in a break with a century of tradition
3 hrs ago
6.9k
88
Rosslare
Man arrested after woman dies following 'serious incident' aboard ferry at Rosslare
Updated
3 hrs ago
89.4k
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 152 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 104 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 136 partners can use this purpose
Use limited data to select advertising 106 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 78 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 77 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 37 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 33 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 127 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 60 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 75 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 82 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 38 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 43 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 25 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 86 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 96 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 68 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 50 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 84 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 64 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say